Back to Blog
Trulieve Sues Florida Over New Marketing Restrictions: What It Means for MMJ Patients

Trulieve Sues Florida Over New Marketing Restrictions: What It Means for MMJ Patients

Trulieve filed a lawsuit challenging Rule 64ER25-6, Florida's emergency regulation restricting cannabis advertising. Learn how it affects patients and deals.

1 views

Trulieve Files Lawsuit Against Florida Department of Health

Trulieve Cannabis, Florida's largest medical marijuana operator with over 160 dispensaries statewide, filed a lawsuit in March 2026 challenging Rule 64ER25-6 — an emergency regulation from the Florida Department of Health that severely restricts how licensed MMTCs can advertise their products. The company calls the rule's conditions "draconian" and "irreparable," arguing it violates their ability to communicate with the 932,000+ registered patients who depend on their services. A separate multi-company legal challenge has a weeklong hearing scheduled for June 22, 2026 before Administrative Law Judge Elizabeth McArthur.

What Rule 64ER25-6 Actually Restricts

Rule 64ER25-6 took effect December 31, 2025 and gave Florida's medical marijuana treatment centers just 90 days to comply with sweeping advertising limitations. Public-facing marketing is now restricted to tightly controlled exterior signage, materials inside dispensaries that are not visible from outside, and limited internet-based activity. The rule bans content that implies recreational use, depicts cannabis consumption, uses celebrities or influencers, or includes imagery considered appealing to children. Previously approved advertising materials are not grandfathered in under the new regulation.

Social Media and Digital Marketing Restrictions Hit Hardest

The digital restrictions under Rule 64ER25-6 are particularly aggressive. All dispensary social media accounts must be registered with the Office of Medical Marijuana Use (OMMU). Paid or targeted digital advertising requires prior state approval before publication. Mobile apps operated by MMTCs may not allow product reservations or purchases — a significant operational hit since most major dispensaries rely on app-based ordering. Companies can also be held liable for marketing actions taken by outside vendors, creating additional compliance risk for operators who use third-party agencies.

Why This Matters for Florida Medical Cannabis Patients

These marketing restrictions directly impact how patients learn about pricing, new products, and promotions at their local dispensaries. With Florida's medical cannabis market generating over 4.18 billion milligrams of THC and 1.42 million ounces of smokable marijuana sold through March 2026, patients rely on dispensary communications to find the best deals. If companies cannot advertise sales, post product photos on social media, or send push notifications through their apps, patients lose a critical tool for comparison shopping in a market where prices vary by 30-50% between dispensaries for equivalent products.

Florida's Broader Cannabis Policy Stalemate

The Trulieve lawsuit arrives during a broader cannabis policy freeze in Florida. The 2026 legislative session ended without advancing adult-use legalization, home cultivation rights, or meaningful patient protections — despite majority voter support for reform. HB 887, which would extend medical cannabis ID cards from one year to two and reduce veteran card fees from $75 to $15, passed the House but stalled in the Senate. The Florida Supreme Court also refused to review the DeSantis administration's decision to invalidate tens of thousands of petition signatures for a 2026 legalization ballot measure, effectively killing recreational cannabis until at least 2028.

22 New MMTC Licenses Could Reshape the Market This Summer

Despite the legislative stalemate, Florida's medical market is poised for expansion. Up to 22 new MMTC licenses could be issued as early as summer 2026, according to CRB Monitor analysis. These licenses stem from applications that have been pending for years, and their approval could introduce new competitors to a market currently dominated by vertically integrated operators like Trulieve, Curaleaf, and The Flowery. More competition historically drives lower prices — which is exactly what patients need in a state where a typical medical cannabis budget runs $200-$400 per month.

How Patients Can Save Money Right Now

While the legal and legislative battles play out, Florida patients can take action today to reduce their cannabis costs. CannaDeals FL tracks daily deals from 22+ dispensaries including Trulieve, Curaleaf, MÜV, and more. Current promotions include first-time patient discounts of 25-50% off, veteran and senior discount programs, and rotating daily specials that can cut your costs by 40% or more. Check today's deals to compare prices across dispensaries, or browse by product category to find the best price on flower, vapes, edibles, and concentrates across the state.